Delivery Order SPE2DB20D1100-SPE2DB25FE4Y5
- Not listed
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for Annovera vaginal rings, with a ceiling value of $6,710.26. This competitively awarded, firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of August 12, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for Annovera vaginal rings with a ceiling value of $1,659.66. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by November 10, 2025. The contract carries no set-aside designation and was awarded...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,756.07 for Annovera vaginal rings under a firm fixed price contract. This non-set-aside delivery order was executed on December 3, 2025, with an ultimate completion date of December 4, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,470.72 to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 16, 2025, with an ultimate completion date of July 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,205.16 to AmerisourceBergen Drug Corp for Annovera vaginal rings on June 17, 2025, with completion scheduled for June 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.12 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded contract represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $7,844.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings on July 11, 2025, with an ultimate completion date of July 14, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location, supplying the...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.03 to AmerisourceBergen Drug Corp for Annovera vaginal rings under a firm fixed-price contract. This non-set-aside award was issued on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,954.22 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $6,224.30 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings under a firm fixed price contract. The award, issued on December 1, 2025, with an ultimate completion date of December 2, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4Y5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings, valued at $3,240 with a firm fixed price and no set-aside designation. The contract, awarded September 5, 2025, is scheduled for completion by September 8, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.999 billion through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies comprehensive pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This competitively awarded delivery order for Annovera contraceptive vaginal rings aligns with the company's established role as a primary pharmaceutical supplier for Defense Health Agency and other federal healthcare systems, enabling the distribution of this specialized medical product to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/5/25 |